Evelo Biosciences, Inc. (EVLO) Social Stream



Evelo Biosciences, Inc. (EVLO): $2.74

-0.15 (-5.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EVLO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Evelo Biosciences Inc (EVLO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EVLO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $41.5 $9 $20.9 $3.23 547.06%
2022-01-31 6 $41.5 $6 $20.3 $3.23 528.48%

The Trend in the Analyst Price Target


Over the past 14 months, EVLO's average price target has gone up $11.3.

EVLO reports an average of 113.27% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 3 36 11 20.20 10.04 101.2%
2021-05-08 6 36 13 21.40 9.54 124.32%
2021-05-15 6 36 13 21.40 10.88 96.69%
2021-05-22 6 36 13 21.40 12.09 77.01%
2021-08-19 6 41 12 22.83 9.11 150.6%

EVLO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


EVLO's average broker recommendation rating improved by 0 over the prior 61 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVLO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Evelo Biosciences Inc's variance in analysts' estimates is lower than -97.38% of them.
  • In terms of how Evelo Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 193.83% of that group.
  • In terms of how Evelo Biosciences Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 155.86% of that group.
  • Evelo Biosciences Inc's average analyst price target is greater than 67.01% of Healthcare stocks.

Stocks similar to Evelo Biosciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, EPIX, and EOLS.

Is EVLO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5013 seconds.